Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 5CNS 2Thoracic 1

Conditions

Brain Neoplasms 129Neoplasm Metastasis 33Glioblastoma 24Melanoma 22Lung Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Breast Neoplasms 15Glioma 12Small Cell Lung Carcinoma 8Neoplasms 8Gliosarcoma 8Central Nervous System Neoplasms 7Neuroma, Acoustic 6Meningioma 6Carcinoma, Renal Cell 6Astrocytoma 5Spinal Cord Neoplasms 4Recurrence 4Sarcoma 3Oligodendroglioma 3Gastrointestinal Neoplasms 3Breast Neoplasms, Male 3Uveal Melanoma 2Radiation Injuries 2Prostatic Neoplasms 2Kidney Neoplasms 2Fatigue 2Depression 2Colorectal Neoplasms 2Anxiety Disorders 2

Interventions

pembrolizumab 2Radiosurgery 2Cyclophosphamide 2pentetreotide 1fludarabine phosphate 1entinostat 1Thrombopoietin 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1LY2940680 1Ipilimumab 1Interleukin-13 1Immunologic Techniques 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Fluorodeoxyglucose F18 1Filgrastim 1Etoposide 1Cryosurgery 1Carboplatin 1CTLA-4 Antigen 1Biopsy 1Amplified Fragment Length Polymorphism Analysis 1ADI PEG20 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uveal Melanoma × Radiosurgery × CNS × Clear all
NCT05341349 2026-04-23

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Emory University

Phase 1 Terminated
1 enrolled
CNSDermatologic

Uveal Melanoma, Brain Neoplasms, Melanoma

NCT02858869 2026-03-09

Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases

Emory University

Phase 1 Completed
25 enrolled 14 charts
CNSDermatologicThoracic

Uveal Melanoma, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡